ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
Promotion
Recombinantタンパク質s ClearClear history
Recombinantタンパク質s CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP IL-2 Hot |FcRn Binding Kit (TR-FRET) New |Claudin 18.2
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > Neprilysin

Neprilysin

概要

Name:Neprilysin
Target Synonym:EC:3.4.24.11,EC 3.4.24,Atriopeptidase,NEP,SFE,Membrane Metallo-Endopeptidase (Neutral Endopeptidase, Enkephalinase, CALLA, CD10),Membrane Metallo-Endopeptidase Variant 1,Membrane Metallo-Endopeptidase Variant 2,Neprilysin-390,Neprilysin-411,CD10 Antigen,EC 3.4.24.11,CMT2T,SCA43,EPN,MME,Enkephalinase,CALLA,Neutral endopeptidase,Common acute lymphocytic leukemia antigen,Neprilysin,CD10,Membrane Metalloendopeptidase,Neutral Endopeptidase 24.11,Skin fibroblast elastase
Number of Launched Drugs:2
Number of Drugs in Clinical Trials:6
Lastest Research Phase:Approved

製品リスト製品比較と製品注文

製品> フィルター結果
製品仕様別：
製品カテゴリー別：
種類別：
タグ別：
コンジュゲート：
製造番号 種類 製品説明 構造 純度 特徴
MME-H521b Human Human Neprilysin / MME / CD10 Protein, Tag Free (active enzyme)
MME-H521b-structure
MME-H521b-sds
MME-H526a Human Human Neprilysin / MME / CD10 Protein, Fc Tag
MME-H526a-structure
MME-H526a-sds
ACRO Quality

Synonym Name

MME,CALLA,CD10,DKFZp686O16152,MGC126681,MGC126707,NEP,SFE,Neprilysin

Background

Cluster of differentiation 10 (CD10) is also known as membrane metallo-endopeptidase, neutral endopeptidase (NEP), Neprilysin, and common acute lymphoblastic leukemia antigen (CALLA), is a 90-110-kDa type II transmembrane glycoprotein normally expressed by a variety of tissues, including epithelial cells of the prostate, kidney, intestine, endometrium, adrenal glands, and lung. This zinc-dependent metalloprotease enzyme cleaves peptide bonds on the amino side of hydrophobic residues and inactivates a variety of physiologically active secreted peptides. CD20 is thought to be the rate-limiting degrading enzyme of amyloid ¦Â peptide (A¦Â) whose abnormal misfolding and aggregation in neural tissue has been implicated in the development of Alzheimer's disease (AD). CD10 is also identified as the common acute lymphoblastic leukemia antigen (CALLA) present on leukemic cells of pre-B phenotype, and thus serves as the most important biomarker in the diagnosis of human acute lymphocytic leukemia (ALL).

Clinical and Translational Updates

公開薬物情報

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Sacubitril/Valsartan Sodium Hydrate LCZ-696; LCZ-696A Approved Novartis Pharma Ag Entresto, 诺欣妥, 科畅欣, Neparvis, ENTRESTO SPRINKLE, Enresuto, Enrest United States Heart Failure Novartis Pharmaceuticals Corp 2015-07-07 Breast Neoplasms; Heart Failure, Systolic; Peripheral Arterial Disease; Ventricular Dysfunction, Left; Lymphoma; Obesity; Cardiovascular Diseases; Hepatic Insufficiency; Essential Hypertension; Erectile Dysfunction; Hypertension; Coronavirus Disease 2019 (COVID-19); Postmyocardial Infarction Syndrome; Heart Diseases; Cardiomyopathy, Hypertrophic; Myocardial Infarction; Renal Insufficiency; Heart Failure Details
Racecadotril Tiorfan; Hidrasec Approved Bioprojet Pharma France Diarrhea Bioprojet Pharma 1993-03-23 Diarrhea, Infantile; Diarrhea Details
Sacubitril/Valsartan Sodium Hydrate LCZ-696; LCZ-696A Approved Novartis Pharma Ag Entresto, 诺欣妥, 科畅欣, Neparvis, ENTRESTO SPRINKLE, Enresuto, Enrest United States Heart Failure Novartis Pharmaceuticals Corp 2015-07-07 Breast Neoplasms; Heart Failure, Systolic; Peripheral Arterial Disease; Ventricular Dysfunction, Left; Lymphoma; Obesity; Cardiovascular Diseases; Hepatic Insufficiency; Essential Hypertension; Erectile Dysfunction; Hypertension; Coronavirus Disease 2019 (COVID-19); Postmyocardial Infarction Syndrome; Heart Diseases; Cardiomyopathy, Hypertrophic; Myocardial Infarction; Renal Insufficiency; Heart Failure Details
Racecadotril Tiorfan; Hidrasec Approved Bioprojet Pharma France Diarrhea Bioprojet Pharma 1993-03-23 Diarrhea, Infantile; Diarrhea Details

臨床試験情報

Name Research Code Research Phase Company Indications Clinical Trials
Dexecadotril Phase 3 Clinical Bioprojet Pharma Gastrointestinal Diseases Details
Debio-0827 PL-37; Debio-0827 Phase 2 Clinical Pharmaleads Pain Details
STR-324 STR-324 Phase 2 Clinical Shanghai Pasteur Institute Of Chinese Academy Of Sciences Acute Pain Details
Sacubitril AHU-377 Phase 2 Clinical Novartis Pharma Ag Heart Failure; Cardiomyopathy, Hypertrophic; Insulin Resistance; Hypertension; Metabolic Diseases; Essential Hypertension; Cardiovascular Diseases; Diabetes Mellitus Details
QR-12000 QR-12000 Phase 2 Clinical Wuhan Createrna Science and Technology Co Ltd Hypertension; Essential Hypertension Details
Dexecadotril Phase 3 Clinical Bioprojet Pharma Gastrointestinal Diseases Details
Debio-0827 PL-37; Debio-0827 Phase 2 Clinical Pharmaleads Pain Details
STR-324 STR-324 Phase 2 Clinical Shanghai Pasteur Institute Of Chinese Academy Of Sciences Acute Pain Details
Sacubitril AHU-377 Phase 2 Clinical Novartis Pharma Ag Heart Failure; Cardiomyopathy, Hypertrophic; Insulin Resistance; Hypertension; Metabolic Diseases; Essential Hypertension; Cardiovascular Diseases; Diabetes Mellitus Details
QR-12000 QR-12000 Phase 2 Clinical Wuhan Createrna Science and Technology Co Ltd Hypertension; Essential Hypertension Details

This web search service is supported by Google Inc.

totopphone
Call us
お問い合わせ
グローバル：+1 800-810-0816(Toll Free)
日本：+(0)81-50-547-99099
Email
メールアドレス
order.jp@acrobiosystems.com
Fax
ファックス
+1 888-377-6111
Address
株式会社アクロバイオシステムズ
〒157-0066
東京都世田谷区成城1丁目26番9-101号

アクロバイオシステムズの公式アカウント

linkedin twitter facebook youtube

お問い合わせ（半角英文字で入力してください）

Copyright © 2017 ACROBiosystems. All Rights Reserved
Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap